Guangdong Annuo Pharmaceutical Co., Ltd.

The purpose of this study is to use indapamide tablets provided by Guangdong Annuo Pharmaceutical Co., Ltd. as the test preparation, and conduct human bioavailability and bioequivalence tests with indapamide tablets (Na-Cai Li) produced by Les Laboratoires Servier in accordance with the relevant provisions of bioequivalence tests. During the study, the safety and tolerability of indapamide tablets were evaluated by changes in adverse event rates, laboratory test results, vital signs, and physical examinations.